Stay updated on Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.

Latest updates to the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page
- Check6 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” was added above the page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record and indicating a site access issue rather than new content.SummaryDifference20%

- Check41 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a new page version; this update does not modify the study content or results.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision tag has been updated to v3.6.6, replacing the previous v3.6.5. This is a minor metadata update and does not change the study details or user-facing content on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now shows a new revision identifier, moving from v3.6.4 to v3.6.5. This reflects a page version update rather than substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.